Literature DB >> 32454024

Plasmacytoid Dendritic Cells and Type I Interferon Promote Extrafollicular B Cell Responses to Extracellular Self-DNA.

Chetna Soni1, Oriana A Perez1, William N Voss2, Joseph N Pucella1, Lee Serpas1, Justin Mehl1, Krystal L Ching1, Jule Goike3, George Georgiou4, Gregory C Ippolito5, Vanja Sisirak6, Boris Reizis7.   

Abstract

Class-switched antibodies to double-stranded DNA (dsDNA) are prevalent and pathogenic in systemic lupus erythematosus (SLE), yet mechanisms of their development remain poorly understood. Humans and mice lacking secreted DNase DNASE1L3 develop rapid anti-dsDNA antibody responses and SLE-like disease. We report that anti-DNA responses in Dnase1l3-/- mice require CD40L-mediated T cell help, but proceed independently of germinal center formation via short-lived antibody-forming cells (AFCs) localized to extrafollicular regions. Type I interferon (IFN-I) signaling and IFN-I-producing plasmacytoid dendritic cells (pDCs) facilitate the differentiation of DNA-reactive AFCs in vivo and in vitro and are required for downstream manifestations of autoimmunity. Moreover, the endosomal DNA sensor TLR9 promotes anti-dsDNA responses and SLE-like disease in Dnase1l3-/- mice redundantly with another nucleic acid-sensing receptor, TLR7. These results establish extrafollicular B cell differentiation into short-lived AFCs as a key mechanism of anti-DNA autoreactivity and reveal a major contribution of pDCs, endosomal Toll-like receptors (TLRs), and IFN-I to this pathway.
Copyright © 2020 Elsevier Inc. All rights reserved.

Entities:  

Keywords:  DNASE1L3; TLR7; TLR9; anti-DNA antibodies; extrafollicular B cell response; plasmacytoid dendritic cells; systemic lupus erythematosus; type I interferon

Mesh:

Substances:

Year:  2020        PMID: 32454024      PMCID: PMC7306002          DOI: 10.1016/j.immuni.2020.04.015

Source DB:  PubMed          Journal:  Immunity        ISSN: 1074-7613            Impact factor:   31.745


  68 in total

1.  Interferon-α induces unabated production of short-lived plasma cells in pre-autoimmune lupus-prone (NZB×NZW)F1 mice but not in BALB/c mice.

Authors:  Alexis Mathian; Mike Gallegos; Virginia Pascual; Jacques Banchereau; Sophie Koutouzov
Journal:  Eur J Immunol       Date:  2011-02-11       Impact factor: 5.532

Review 2.  Extrafollicular responses in humans and SLE.

Authors:  Scott A Jenks; Kevin S Cashman; Matthew C Woodruff; F Eun-Hyung Lee; Ignacio Sanz
Journal:  Immunol Rev       Date:  2019-03       Impact factor: 12.988

3.  B-lymphocyte development is regulated by the combined dosage of three basic helix-loop-helix genes, E2A, E2-2, and HEB.

Authors:  Y Zhuang; P Cheng; H Weintraub
Journal:  Mol Cell Biol       Date:  1996-06       Impact factor: 4.272

Review 4.  Dysregulation of germinal centres in autoimmune disease.

Authors:  Carola G Vinuesa; Iñaki Sanz; Matthew C Cook
Journal:  Nat Rev Immunol       Date:  2009-12       Impact factor: 53.106

5.  Genetic evidence for the role of plasmacytoid dendritic cells in systemic lupus erythematosus.

Authors:  Vanja Sisirak; Dipyaman Ganguly; Kanako L Lewis; Coline Couillault; Lena Tanaka; Silvia Bolland; Vivette D'Agati; Keith B Elkon; Boris Reizis
Journal:  J Exp Med       Date:  2014-09-01       Impact factor: 14.307

6.  Epistatic Interactions Between Mutations of Deoxyribonuclease 1-Like 3 and the Inhibitory Fc Gamma Receptor IIB Result in Very Early and Massive Autoantibodies Against Double-Stranded DNA.

Authors:  Thomas Weisenburger; Bettina von Neubeck; Andrea Schneider; Nadja Ebert; Daniel Schreyer; Andreas Acs; Thomas H Winkler
Journal:  Front Immunol       Date:  2018-07-05       Impact factor: 7.561

7.  Type-I interferon receptor deficiency reduces lupus-like disease in NZB mice.

Authors:  Marie-Laure Santiago-Raber; Roberto Baccala; Katarina M Haraldsson; Divaker Choubey; Timothy A Stewart; Dwight H Kono; Argyrios N Theofilopoulos
Journal:  J Exp Med       Date:  2003-03-17       Impact factor: 14.307

8.  Interferon and granulopoiesis signatures in systemic lupus erythematosus blood.

Authors:  Lynda Bennett; A Karolina Palucka; Edsel Arce; Victoria Cantrell; Josef Borvak; Jacques Banchereau; Virginia Pascual
Journal:  J Exp Med       Date:  2003-03-17       Impact factor: 14.307

9.  B-Cell-Intrinsic Type 1 Interferon Signaling Is Crucial for Loss of Tolerance and the Development of Autoreactive B Cells.

Authors:  Phillip P Domeier; Sathi Babu Chodisetti; Stephanie L Schell; Yuka Imamura Kawasawa; Melinda J Fasnacht; Chetna Soni; Ziaur S M Rahman
Journal:  Cell Rep       Date:  2018-07-10       Impact factor: 9.423

10.  Dnase1l3 deletion causes aberrations in length and end-motif frequencies in plasma DNA.

Authors:  Lee Serpas; Rebecca W Y Chan; Peiyong Jiang; Meng Ni; Kun Sun; Ali Rashidfarrokhi; Chetna Soni; Vanja Sisirak; Wing-Shan Lee; Suk Hang Cheng; Wenlei Peng; K C Allen Chan; Rossa W K Chiu; Boris Reizis; Y M Dennis Lo
Journal:  Proc Natl Acad Sci U S A       Date:  2018-12-28       Impact factor: 11.205

View more
  32 in total

Review 1.  Type I Interferons in Autoimmunity.

Authors:  Ruth Fernandez-Ruiz; Timothy B Niewold
Journal:  J Invest Dermatol       Date:  2022-01-10       Impact factor: 8.551

Review 2.  Targeting TFH cells in human diseases and vaccination: rationale and practice.

Authors:  Di Yu; Lucy S K Walker; Zheng Liu; Michelle A Linterman; Zhanguo Li
Journal:  Nat Immunol       Date:  2022-07-11       Impact factor: 31.250

Review 3.  New insights into macrophage subsets in atherosclerosis.

Authors:  Yurong Wang; Qiong Wang; Danyan Xu
Journal:  J Mol Med (Berl)       Date:  2022-08-05       Impact factor: 5.606

Review 4.  T cell help in the autoreactive germinal center.

Authors:  Elliot H Akama-Garren; Michael C Carroll
Journal:  Scand J Immunol       Date:  2022-05-31       Impact factor: 3.889

Review 5.  Type I interferon in the pathogenesis of systemic lupus erythematosus.

Authors:  Mariana Postal; Jessica F Vivaldo; Ruth Fernandez-Ruiz; Jacqueline L Paredes; Simone Appenzeller; Timothy B Niewold
Journal:  Curr Opin Immunol       Date:  2020-11-24       Impact factor: 7.486

Review 6.  The Role of Nucleases and Nucleic Acid Editing Enzymes in the Regulation of Self-Nucleic Acid Sensing.

Authors:  Pauline Santa; Anne Garreau; Lee Serpas; Amandine Ferriere; Patrick Blanco; Chetna Soni; Vanja Sisirak
Journal:  Front Immunol       Date:  2021-02-26       Impact factor: 7.561

7.  Interferon α Enhances B Cell Activation Associated With FOXM1 Induction: Potential Novel Therapeutic Strategy for Targeting the Plasmablasts of Systemic Lupus Erythematosus.

Authors:  Kanae Akita; Ken Yasaka; Tsuyoshi Shirai; Tomonori Ishii; Hideo Harigae; Hiroshi Fujii
Journal:  Front Immunol       Date:  2021-02-03       Impact factor: 7.561

8.  Erythroid mitochondrial retention triggers myeloid-dependent type I interferon in human SLE.

Authors:  Simone Caielli; Jacob Cardenas; Adriana Almeida de Jesus; Jeanine Baisch; Lynnette Walters; Jean Philippe Blanck; Preetha Balasubramanian; Cristy Stagnar; Marina Ohouo; Seunghee Hong; Lorien Nassi; Katie Stewart; Julie Fuller; Jinghua Gu; Jacques F Banchereau; Tracey Wright; Raphaela Goldbach-Mansky; Virginia Pascual
Journal:  Cell       Date:  2021-08-11       Impact factor: 66.850

Review 9.  Revisiting B cell tolerance and autoantibodies in seropositive and seronegative autoimmune rheumatic disease (AIRD).

Authors:  J N Pouw; E F A Leijten; J M van Laar; M Boes
Journal:  Clin Exp Immunol       Date:  2020-11-15       Impact factor: 4.330

Review 10.  Regulation of the nucleic acid-sensing Toll-like receptors.

Authors:  Nicholas A Lind; Victoria E Rael; Kathleen Pestal; Bo Liu; Gregory M Barton
Journal:  Nat Rev Immunol       Date:  2021-07-16       Impact factor: 108.555

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.